UNSPSC 51260000: Adrenergic blocking agents

This classification denotes drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine.

UNSPSC 51260000 Adrenergic blocking agents is a Family code that, based on recent state and local solicitation activity, encompasses pharmaceutical products used in emergency response and public health interventions rather than traditional adrenergic medications. Seminole County, Florida has solicited naloxone (an opioid antagonist) and drug deactivation systems through competitive bidding, signaling that the code captures life-safety pharmaceuticals and related harm-reduction products procured by county health departments and community health agencies. The scope includes annual supply contracts with quarterly delivery schedules, fixed-fee pricing models, and standard vendor compliance requirements such as drug-free workplace certification, E-Verify authorization, workers' compensation insurance, and professional liability coverage. Issuing bodies under this code include county government health agencies and community health departments responsible for emergency response and overdose prevention initiatives.

Seminole County, Florida represents the documented recent activity under this code. The county posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract structure includes a two-year initial term with an optional one-year renewal, electronic bid submission through the county's e-Procurement Portal, and potential FEMA funding with associated federal compliance requirements. Vendors must include all shipping and delivery costs in their proposals and provide unit pricing for each line item. The procurement does not designate explicit set-asides for small, minority, or women-owned businesses.